Evidence map›Paper›PMID 37026007›Full record

ArticleFrontiers in immunology2023

Case report: Rapid development of amyloid A amyloidosis in temporal arteritis with

Shuhei Yoshida, Haruki Matsumoto, Jumpei Temmoku, Norshalena Shakespear, Yuichiro Kiko, Kentaro Kikuchi, Yuya Sumichika, Kenji Saito, Yuya Fujita, Naoki Matsuoka and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Secondary Amyloidosis Treated with Tocilizumab as a Complication of Temporal Arteritis.European journal of case reports in internal medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Shuhei YoshidaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Haruki MatsumotoDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Jumpei TemmokuDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Norshalena ShakespearDepartment of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Yuichiro KikoDepartment of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Kentaro KikuchiDepartment of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Yuya SumichikaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Kenji SaitoDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Yuya FujitaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Naoki MatsuokaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Tomoyuki AsanoDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Shuzo SatoDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Eiji SuzukiDepartment of Rheumatology, Ohta-Nishinouchi Hospital, Koriyama, Japan.
Hiroshi WatanabeDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Hiromasa OhiraDepartment of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Kiyoshi MigitaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Fukushima Medical University · JPOhta Nishinouchi Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Temporal arteritis (TA) is a large-vessel vasculitis mostly seen in older patients. Amyloid A (AA) amyloidosis secondary to a chronic inflammation induces multiple organ dysfunctions, including a dysfunction of the gastrointestinal tract. Herein, we present a case of TA complicated by AA amyloidosis that was resistant to oral and intravenous steroids. An 80-year-old man with a history of new-onset headache, jaw claudication, and distended temporal arteries was referred to our department. On admission, the patient presented with tenderness and a subcutaneous temporal nodule in both temple arteries. Ultrasonography of the nodule revealed an anechoic perivascular halo surrounding the right temporal artery. Following the diagnosis of TA, high-dose prednisolone therapy was initiated. However, the patient presented with recurrent abdominal pain and refractory diarrhea. Due to the unclear origin of refractory diarrhea, an extensive workup, including biopsy of the duodenal mucosa, was performed. Endoscopy revealed chronic inflammation in the duodenum. Immunohistochemical analysis of duodenal mucosal biopsy samples revealed AA amyloid deposition resulting in the diagnosis of AA amyloidosis. After tocilizumab (TCZ) administration, refractory diarrhea reduced; however, the patient died of intestinal perforation 1 month after the start of TCZ administration. Gastrointestinal involvement was the main clinical manifestation of AA amyloidosis in the present case. This case highlights the importance of bowel biopsy screening for amyloid deposition in patients with unexplained gastrointestinal tract symptoms, even in a recent onset of large-vessel vasculitis. In the present case, the carriage of the

Indexed as

AmyloidosisGiant Cell ArteritisAged, 80 and overAllelesDiarrheaHumansInflammationMaleSerum Amyloid A ProteinSAA1 protein, humanSerum Amyloid A Proteinamyloid A amyloidosislarge-vessel vasculitisSAA1 polymorphismserum amyloid Atemporal arthritistocilizumab

Identifiers

PMID37026007
PMCPMC10071027
OpenAlexW4328118496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.